Delegierte Verordnung (EU) 2024/197 der Kommission vom 19. Oktober 2023 zur Änderung der Verordnung (EG) Nr. 1272/2008 hinsichtlich der harmonisierten Einstufung und Kennzeichnung bestimmter Stoffe

Amtliche Ursprungsfassung

Quellenkennung: 32024R0197. Spätere Änderungen sind nicht automatisch in dieser Fassung enthalten.

Zur amtlichen Quelle ↗

Durchsuchbarer Text in vereinfachter Darstellung. Tabellen, Abbildungen und verbindliche Gestaltung bitte anhand der Originaldateien prüfen.

H319 H317 H400 Oral: ATE = 500 mg/kg KG M = 1“ „604-074-00-0 2,2‘,6,6’-Tetrabrom-4,4’-isopropylidenediphenol; Tetrabrombisphenol-A 201-236-9 79-94-7 Carc. 1B Aquatic Acute 1 Aquatic Chronic 1 H350 H400 H410 GHS08 GHS09 Dgr H350 H410“ „606-034-00-8 Metribuzin (ISO); 4-Amino-6-tert-butyl-3-methylthio-1,2,4-triazin-5(4H)-on; 4-Amino-4,5-dihydro-6-(1,1-dimethylethyl)-3-methylthio-1,2,4-triazin-5-on 244-209-7 21087-64-9 Acute Tox. 4 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1 H302 H373 (Blutkreislauf) H400 H410 GHS07 GHS08 GHS09 Wng H302 H373 (Blutkreislauf) H410 Oral: ATE = 320 mg/kg KG M = 10 M = 10“ „607-032-00-X Ethylacrylat 205-438-8 140-88-5 Flam. Liq. 2 Acute Tox. 3 Acute Tox. 4 Acute Tox. 4 STOT SE 3 Skin Irrit. 2 Eye Irrit. 2 Skin Sens. 1 H225 H331 H312 H302 H335 H315 H319 H317 GHS02 GHS06 Dgr H225 H331 H312 H302 H335 H315 H319 H317 Inhalation: ATE = 9 mg/L (Dämpfe) dermal: ATE = 1 800 mg/kg KG Oral: ATE = 1 120 mg/kg KG STOT SE 3; H335: C ≥ 5 % Skin Irrit. 2; H315: C ≥ 5 % Eye Irrit. 2; H319: C ≥ 5 % D“ „607-034-00-0 Methylacrylat; Methlproenoat 202-500-6 96-33-3 Flam. Liq. 2 Acute Tox. 3 Acute Tox. 4 Acute Tox. 4 STOT SE 3 Skin Irrit. 2 Eye Irrit. 2 Skin Sens. 1 H225 H331 H312 H302 H335 H315 H319 H317 GHS02 GHS06 Dgr H225 H331 H312 H302 H335 H315 H319 H317 Inhalation: ATE = 3 mg/L (Dämpfe) dermal: ATE = 1 100 mg/kg KG Oral: ATE = 500 mg/kg KG D“ „607-223-00-8 Transfluthrin (ISO); 2,3,5,6-Tetrafluorbenzyl (1R,3S)-3-(2,2-dichlorvinyl)-2,2-dimethylcyclopropancarboxylat 405-060-5 118712-89-3 Carc. 2 Acute Tox. 4 STOT SE 1 Aquatic Acute 1 Aquatic Chronic 1 H351 H302 H370 (Nervensystem) H400 H410 GHS08 GHS07 GHS09 Wng H351 H302 H370 (Nervensystem) H410 EUH066 Oral: ATE = 580 mg/kg KG M = 1 000 M = 1 000 “ „607-246-00-3 Allylmethacrylat; 2-Methyl-2-propensäure 2-propenylester 202-473-0 96-05-9 Flam. Liq. 3 Acute Tox. 2 Acute Tox. 3 Acute Tox. 4 Aquatic Acute 1 H226 H330 H311 H302 H400 GHS02 GHS06 GHS09 Dgr H226 H330 H311 H302 H400 Inhalation: ATE = 1,5 mg/L (Dämpfe) dermal: ATE = 300 mg/kg KG Oral: ATE = 400 mg/kg KG“ „612-004-00-5 Triethylamin 204-469-4 121-44-8 Flam. Liq. 2 Acute Tox. 3 Acute Tox. 3 Acute Tox. 3 Skin Corr. 1A Eye Dam. 1 H225 H331 H311 H301 H314 H318 GHS02 GHS06 GHS05 Dgr H225 H331 H311 H301 H314 Inhalation: ATE = 7,2 mg/L (Dämpfe) dermal: ATE = 300 mg/kg KG oral: ATE = 100 mg/kg KG STOT SE 3; H335: C ≥ 1 %“ „612-049-00-0 Di-n-Butylamin 203-921-8 111-92-2 Flam. Liq. 3 Acute Tox. 2 Acute Tox. 3 Acute Tox. 3 Skin Corr. 1B Eye Dam. 1 H226 H330 H311 H301 H314 H318 GHS02 GHS06 GHS05 Dgr H226 H330 H311 H301 H314 EUH 071 Inhalation: ATE = 1,2 mg/L (Dämpfe) dermal: ATE = 300 mg/kg KG Oral: ATE = 220 mg/kg KG“ „612-056-00-9 N,N-Dimethyl-m-toluidin; [1] N,N-Dimethyl-o-toluidin [2] 204-495-6 [1] 210-199-8 [2] 121-72-2 [1] 609-72-3 [2] Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 2 * Aquatic Chronic 3 H331 H311 H301 H373 ** H412 GHS06 GHS08 Dgr H331 H311 H301 H373 ** H412 * C“ „613-088-00-6 1,2-Benzisothiazol-3(2H)-on; 1,2-Benzisothiazolin-3-on 220-120-9 2634-33-5 Acute Tox. 2 Acute Tox. 4 Skin Irrit. 2 Eye Dam. 1 Skin Sens. 1A Aquatic Acute 1 Aquatic Chronic 1 H330 H302 H315 H318 H317 H400 H410 GHS06 GHS05 GHS09 Dgr H330 H302 H315 H318 H317 H410 Inhalation: ATE = 0,21 mg/L (Stäube oder Nebel) Oral: ATE = 450 mg/kg KG Skin Sens. 1A; H317: C ≥ 0,036 % M = 1 M = 1“ „613-127-00-7 Mepiquatchlorid (ISO); 1,1-Dimethylpiperidiniumchlorid 246-147-6 24307-26-4 Acute Tox. 4 Acute Tox. 3 Aquatic Chronic 3 H332 H301 H412 GHS06 Dgr H332 H301 H412 Inhalation: ATE = 2,8 mg/L (Stäube oder Nebel) Oral: ATE = 270 mg/kg KG“ „613-307-00-5 Clothianidin (ISO); (E)-1-(2-Chlor-1,3-thiazol-5-ylmethyl)-3-methyl-2-nitroguanidin 433-460-1 210880-92-5 Repr. 2 Acute Tox. 4 STOT SE 1 Aquatic Acute 1 Aquatic Chronic 1 H361f H302 H370 (Nervensystem) H400 H410 GHS08 GHS07 GHS09 Dgr H361f H302 H370 (Nervensystem) H410 Oral: ATE = 390 mg/kg KG M = 10 M = 100“ „616-035-00-5 Cymoxanil (ISO); 2-Cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamid; [1] (2E)-2-Cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamid; [2] 261-043-0 [1] - [2] 57966-95-7 [1] 166900-80-7 [2] Repr. 2 Acute Tox. 4 STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1 H361fd H302 H373 (Blutkreislauf, Thymusdrüse, Augen) H317 H400 H410 GHS08 GHS07 GHS09 Wng H361fd H302 H373 (Blutkreislauf, Thymusdrüse, Augen) H317 H410 Oral: ATE = 360 mg/kg KG M = 1 M = 1“ „616-104-00-X Benalaxyl (ISO); Methyl-N-(2,6-dimethylphenyl)-N-(phenylacetyl)-DL-alaninat. 275-728-7 71626-11-4 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1 H302 H400 H410 GHS07 GHS09 Wng H302 H410 Oral: ATE = 1 000 mg/kg KG M = 1 M = 1“ ELI: http://data.europa.eu/eli/reg_del/2024/197/oj ISSN 1977-0642 (electronic edition)